← Leaderboards
Phillip R Morrow
Avanir Pharmaceuticals
$100,000
Attributed
$100,000
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$100,000 · 1
By mechanism
R43$100,000 · 1
Top collaborators
No co-investigators on record.
Most similar at Avanir Pharmaceuticals
Same institution · by research overlap
- Angray S Kang$499,915
- Wolfgang W Scholz$5,224,945
Others in their field
Top investigators on “Anthrax”
- Laurence Lemiale · Emergent Product Development Gaithersbur$61,222,506
- Matthew Duchars$38,000,000
- Sukjoon Park · Emergent Product Development Gaithersbur$31,173,473
- Daniel F. Hoft · Saint Louis University$26,271,892
- David Heimbrook · Leidos Biomedical Research, Inc.$21,781,988
- Donald S. Burke · Johns Hopkins University$21,607,962
Research focus
AnthraxAntiantibodyAntibody FormationAntigen Antibody ReactionBacillus AnthracisBacterial AntigensBacterial ToxinsBioterrorism /Chemical WarfareCell LineClinical ResearchEnzyme Linked Immunosorbent AssayHuman TissueImmunologic Substance Development /PreparationLeukocytesMonoclonal AntibodyNeutralizing AntibodyPolymerase Chain ReactionScid MouseSurface Plasmon Resonance